Xometry, Inc. $XMTR Stock Position Trimmed by Faithward Advisors LLC

Faithward Advisors LLC cut its holdings in shares of Xometry, Inc. (NASDAQ:XMTR) by 6.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 241,802 shares of the company’s stock after selling 15,319 shares during the quarter. Xometry makes up 2.0% of Faithward Advisors LLC’s investment portfolio, making the stock its 9th largest holding. Faithward Advisors LLC owned 0.47% of Xometry worth $13,171,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Quantbot Technologies LP purchased a new position in shares of Xometry in the 3rd quarter worth about $30,000. Advisors Asset Management Inc. increased its holdings in Xometry by 68.3% during the second quarter. Advisors Asset Management Inc. now owns 1,015 shares of the company’s stock worth $34,000 after buying an additional 412 shares during the last quarter. Westend Capital Management LLC bought a new stake in Xometry in the third quarter worth about $41,000. Global Retirement Partners LLC bought a new stake in Xometry in the third quarter worth about $47,000. Finally, KBC Group NV purchased a new position in Xometry in the second quarter valued at about $55,000. 97.31% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Xometry news, CEO Randolph Altschuler sold 31,928 shares of the business’s stock in a transaction on Thursday, February 26th. The shares were sold at an average price of $43.44, for a total transaction of $1,386,952.32. Following the sale, the chief executive officer owned 372,377 shares of the company’s stock, valued at $16,176,056.88. The trade was a 7.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Subir Dutt sold 3,929 shares of the stock in a transaction on Monday, January 5th. The stock was sold at an average price of $65.55, for a total value of $257,545.95. Following the sale, the insider owned 67,419 shares in the company, valued at approximately $4,419,315.45. This represents a 5.51% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 127,852 shares of company stock worth $6,993,940 in the last three months. Insiders own 9.66% of the company’s stock.

Xometry Price Performance

Shares of NASDAQ:XMTR opened at $38.78 on Wednesday. The firm has a market capitalization of $2.01 billion, a PE ratio of -31.79 and a beta of 0.90. The company has a quick ratio of 3.72, a current ratio of 3.76 and a debt-to-equity ratio of 1.18. The company has a 50-day moving average price of $55.19 and a two-hundred day moving average price of $55.58. Xometry, Inc. has a twelve month low of $18.59 and a twelve month high of $73.87.

Xometry (NASDAQ:XMTR) last posted its quarterly earnings results on Tuesday, February 24th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.04. The company had revenue of $192.40 million for the quarter, compared to analyst estimates of $183.37 million. Xometry had a negative net margin of 8.99% and a negative return on equity of 5.49%. The company’s quarterly revenue was up 29.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.06 earnings per share. Equities analysts forecast that Xometry, Inc. will post -0.66 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on XMTR. William Blair reissued an “outperform” rating on shares of Xometry in a research report on Tuesday, February 24th. Citigroup lowered their price target on shares of Xometry from $75.00 to $65.00 and set a “buy” rating on the stock in a report on Wednesday, February 25th. UBS Group upped their price objective on Xometry from $54.00 to $55.00 and gave the company a “neutral” rating in a research note on Wednesday, February 25th. Wedbush reduced their price objective on Xometry from $70.00 to $60.00 and set an “outperform” rating for the company in a report on Wednesday, February 25th. Finally, Zacks Research raised Xometry from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Five equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Xometry currently has a consensus rating of “Hold” and a consensus price target of $62.00.

Xometry Company Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.